Literature DB >> 15461857

Alternative sources of fibrinolytic, anticoagulative, antimicrobial and anticancer molecules.

E L Cooper1, T M Hrzenjak, M Grdisa.   

Abstract

The medicinal properties of earthworms in various remedies date back to 1340 A.D. and have been extended to other countries and cultures. Assays of tissue homogenates of earthworm (Eisenia foetida) have revealed a glycolipoprotein mixture referred to as G-90 that is composed of macromolecules with medical and pharmaceutical applications. There are several functions attributed to G-90: possession of several growth factors that: stimulate proliferation in cell cultures, contain an insulin like growth factor (IGF like), an immunoglobulin like growth factor (IgFG-like), possess two serine peptidases with a tyrosine code and epidermal growth factor (EGF). In contrast, G-90 exerts strong fibrinolytic and anticoagulative activity capable of lysing fibrin clots. Actions of these two properties are dependent upon concentration. Anti-coagulative activity also depends upon the kind of anticoagulants (G-90, PI, PII). G-90 can also act as antioxidant, exert antimicrobial activities in vitro and in vivo. The bacteriostatic effect is significantly greater for non-pathogenic species. Finally G-90 also participates in tissue regeneration and wound healing. Taken together, components of earthworms could be tested in certain clinical trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15461857     DOI: 10.1177/039463200401700303

Source DB:  PubMed          Journal:  Int J Immunopathol Pharmacol        ISSN: 0394-6320            Impact factor:   3.219


  17 in total

Review 1.  Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancements.

Authors:  K K Pulicherla; Mahendra Kumar Verma
Journal:  AAPS PharmSciTech       Date:  2015-01-23       Impact factor: 3.246

2.  Selective Th2 Upregulation by Crocus sativus: A Neutraceutical Spice.

Authors:  Sarang Bani; Anjali Pandey; Vijai K Agnihotri; Vijaylata Pathania; Bikram Singh
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-13       Impact factor: 2.629

3.  Dilong: role in peripheral nerve regeneration.

Authors:  Yung-Ming Chang; Wei-Yi Chi; Tung-Yuan Lai; Yueh-Sheng Chen; Fuu-Jen Tsai; Chang-Hai Tsai; Wei-Wen Kuo; Yi-Chang Cheng; Chien-Chung Lin; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-15       Impact factor: 2.629

4.  eCAM benefits from diversity that derives from CAM.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2005-09       Impact factor: 2.629

5.  Drug Discovery, CAM and Natural Products.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-12       Impact factor: 2.629

6.  Earthworms dilong: ancient, inexpensive, noncontroversial models may help clarify approaches to integrated medicine emphasizing neuroimmune systems.

Authors:  Edwin L Cooper; Mariappan Balamurugan; Chih-Yang Huang; Clara R Tsao; Jesus Heredia; Mila Tommaseo-Ponzetta; Maurizio G Paoletti
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-25       Impact factor: 2.629

7.  Schwann Cell Migration Induced by Earthworm Extract via Activation of PAs and MMP2/9 Mediated through ERK1/2 and p38.

Authors:  Yung-Ming Chang; Ying-Ting Shih; Yueh-Sheng Chen; Chien-Liang Liu; Wen-Kuei Fang; Chang-Hai Tsai; Fuu-Jen Tsai; Wei-Wen Kuo; Tung-Yuan Lai; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-04       Impact factor: 2.629

8.  RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I.

Authors:  Yung-Ming Chang; Wu-Hsien Kuo; Tung-Yuan Lai; Ying-Ting Shih; Fuu-Jen Tsai; Chang-Hai Tsai; Wen-Tong Shu; Ying-Yu Chen; Yueh-Sheng Chen; Wei-Wen Kuo; Chih-Yang Huang
Journal:  Evid Based Complement Alternat Med       Date:  2011-06-08       Impact factor: 2.629

9.  Commentary on CAM and NK Cells by Kazuyoshi Takeda and Ko Okumura.

Authors:  Edwin L. Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-06-01       Impact factor: 2.629

10.  Commentary on Traditional and Modern Biomedical Prospecting: Part II-The Benefits by Werner E.G. Muller, Heinz C. Schroder, Matthias Wiens, Sanja Perovic-Ottstadt, Renato Batel and Isabel M. Muller: Anti-protozoa and antiviral activities of non-cytotoxic truncated and variant analogues of mussel defensin by P. Roch, A. Beschin and E. Bernard.

Authors:  Edwin L Cooper
Journal:  Evid Based Complement Alternat Med       Date:  2004-09-01       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.